Acrivon Therapeutics Inc....

1.50
-0.14 (-8.54%)
At close: Apr 04, 2025, 3:59 PM
1.55
3.64%
After-hours: Apr 04, 2025, 05:03 PM EDT

Acrivon Therapeutics Common Stock Revenue

Acrivon Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Acrivon Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
75
Market Cap
47.03M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a